Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3851547

Fc1ccc(-c2cnc3ccc(-c4c[nH]nc4-c4ccccc4F)cn23)cc1F.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 15/20 0.39
PRMT5 O14744 3/20 0.36
WDR77 Q9BQA1 3/20 0.36
TGFBR2 P37173 6/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA3 P34903 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3849822 0.92 TGFBR1 (0.37) TGFBR1PRMT5WDR77TGFBR2
Trifluoroacetic Acid SCHEMBL3852891 0.91 TGFBR1 (0.38) TGFBR1PRMT5WDR77TGFBR2GABRA1
Trifluoroacetic Acid SCHEMBL3845848 0.88 FYN (0.42)
Trifluoroacetic Acid SCHEMBL3852898 0.84 TGFBR1 (0.38) TGFBR1PRMT5WDR77TGFBR2
SCHEMBL13874552 0.83 CLK1 (0.41) TGFBR1PRMT5WDR77TGFBR2
SCHEMBL13874245 0.82 FLT3 (0.48) TGFBR1PRMT5WDR77TGFBR2
Hydrochloric Acid SCHEMBL4714547 0.81 FLT3 (0.47) TGFBR1PRMT5WDR77TGFBR2
Trifluoroacetic Acid SCHEMBL5851891 0.79 TGFBR1 (0.36) TGFBR1
Trifluoroacetic Acid SCHEMBL3850035 0.79 FYN (0.43)
Trifluoroacetic Acid SCHEMBL3854224 0.79 TGFBR1 (0.36) TGFBR1MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed